Tiova Inhaler for Effective COPD Symptom Control
| Product dosage: 200 MD | |||
|---|---|---|---|
| Package (num) | Per inhaler | Price | Buy |
| 6 | $12.75 | $76.48 (0%) | 🛒 Add to cart |
| 10 | $9.56
Best per inhaler | $127.46 $95.59 (25%) | 🛒 Add to cart |
Tiova Inhaler (Tiotropium Bromide) is a long-acting muscarinic antagonist (LAMA) bronchodilator designed for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the muscles around the airways, making breathing easier for patients. Administered once daily via the Respimat Soft Mist Inhaler, it offers consistent 24-hour symptom relief, improved lung function, and enhanced exercise tolerance. This inhaler is indicated for adults and should be used as part of a comprehensive COPD management plan under medical supervision.
Features
- Contains Tiotropium Bromide 9 mcg per puff
- Delivered via the Respimat Soft Mist Inhaler for efficient lung deposition
- Once-daily dosing regimen for patient convenience
- Pre-measured, consistent dosage with each actuation
- Portable, handheld device with dose indicator
- Prescription-only medication requiring healthcare provider authorization
Benefits
- Provides sustained 24-hour bronchodilation for round-the-clock breathing control
- Reduces frequency and severity of COPD exacerbations
- Improves lung function as measured by FEV1 (Forced Expiratory Volume in 1 second)
- Enhances exercise capacity and overall quality of life
- Minimizes the need for rescue inhalers through proactive symptom management
- Easy-to-use inhaler device suitable for elderly patients or those with reduced hand strength
Common use
Tiova Inhaler is primarily prescribed for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). It is not indicated for the relief of acute bronchospasm. Clinical use focuses on reducing the progression of symptoms, decreasing exacerbation rates, and improving overall pulmonary function. It may be used as monotherapy or in combination with other long-acting bronchodilators or inhaled corticosteroids, depending on disease severity and treatment goals as per GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines.
Dosage and direction
The recommended dosage of Tiova Inhaler is two puffs (total 18 mcg of Tiotropium Bromide) once daily, at the same time each day. Administration should be performed using the Respimat inhaler device as follows:
- Hold the inhaler upright with the cap closed.
- Turn the base in the direction of the arrows until it clicks.
- Exhale fully away from the mouthpiece.
- Place the mouthpiece between lips, ensuring a tight seal.
- Press the dose-release button while slowly inhaling deeply.
- Hold breath for 10 seconds, then exhale slowly.
The device must be primised before first use by actuating toward the ground until a mist is visible, then repeat three more times. No shaking is required. Patients should receive proper inhaler technique training from a healthcare professional.
Precautions
- Not for use in the treatment of acute bronchospasm; always keep a fast-acting rescue inhaler available.
- Use with caution in patients with narrow-angle glaucoma, prostatic hyperplasia, or bladder-neck obstruction due to anticholinergic effects.
- Monitor for signs of paradoxical bronchospasm; discontinue immediately if it occurs.
- Avoid contact with eyes, as it may cause pupil dilation and blurred vision or worsen glaucoma.
- Not recommended for patients with severe renal impairment (creatinine clearance ≤30 mL/min); use with caution in moderate impairment.
- Inform healthcare provider of all current medications to avoid potential interactions.
- Pregnancy Category C: use only if potential benefit justifies potential risk to the fetus.
Contraindications
Tiova Inhaler is contraindicated in patients with a known hypersensitivity to Tiotropium Bromide, atropine or its derivatives, or any component of the formulation. It must not be used for the initial treatment of acute episodes of bronchospasm where rapid response is required. Contraindicated in patients with a history of hypersensitivity reactions such as rash, urticaria, or angioedema to anticholinergic agents.
Possible side effect
Common side effects (≥1% incidence) may include:
- Dry mouth
- Upper respiratory tract infection
- Sinusitis
- Pharyngitis
- Constipation
- Dyspepsia
- Headache
Less common but serious side effects requiring medical attention:
- Immediate hypersensitivity reactions (e.g., angioedema, rash)
- Worsening of narrow-angle glaucoma symptoms (eye pain, blurred vision)
- Urinary retention, especially in patients with prostatic hyperplasia
- Paradoxical bronchospasm
- Tachycardia or palpitations
- Dizziness or blurred vision
Drug interaction
Tiotropium Bromide may interact with other anticholinergic medications (e.g., ipratropium, aclidinium, glycopyrrolate), potentially increasing the risk of side effects such as dry mouth, urinary retention, or constipation. Concurrent use with beta-adrenergic drugs (e.g., salmeterol, formoterol) may have additive bronchodilator effects but is generally considered safe under medical supervision. No clinically significant pharmacokinetic interactions have been observed with cytochrome P450-metabolized drugs. However, always disclose all medications, including over-the-counter drugs and supplements, to the prescribing physician.
Missed dose
If a dose of Tiova Inhaler is missed, it should be taken as soon as remembered on the same day. However, if it is nearly time for the next scheduled dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining a consistent once-daily routine is important for optimal therapeutic effect.
Overdose
Overdose may lead to exaggerated anticholinergic effects such as severe dry mouth, visual disturbances, tachycardia, urinary retention, constipation, and possible CNS effects like nervousness or dizziness. There is no specific antidote for Tiotropium Bromide overdose. Treatment is supportive and symptomatic. In case of suspected overdose, discontinue the medication immediately and seek medical attention. Dialysis is not likely to be effective due to high protein binding and extensive tissue distribution.
Storage
Store Tiova Inhaler at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and freezing. Keep the cap closed when not in use to protect the mouthpiece from contamination and moisture. Do not puncture or incinerate the cartridge, even when empty. Keep out of reach of children and pets. The inhaler should be discarded 3 months after first use or when the dose indicator shows zero, whichever comes first.
Disclaimer
This information is intended for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations based on your medical history and current condition. Do not initiate, discontinue, or change the dosage of any medication without consulting your physician. Individual responses to medication may vary.
Reviews
Clinical studies and patient reports consistently demonstrate the efficacy of Tiova Inhaler in managing COPD symptoms. In randomized controlled trials, it showed significant improvement in trough FEV1 compared to placebo and sustained quality of life enhancements. Many patients report reduced breathlessness, fewer exacerbations, and greater ability to perform daily activities. Some users note the convenience of once-daily dosing, though a minority report dry mouth or mild throat irritation. Adherence to proper inhaler technique is frequently emphasized as critical for optimal results.